pd 98059 has been researched along with Aggressive Natural Killer Cell Leukemia in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mizutani, N | 1 |
| Ito, H | 1 |
| Hagiwara, K | 1 |
| Kobayashi, M | 1 |
| Hoshikawa, A | 1 |
| Nishida, Y | 1 |
| Takagi, A | 1 |
| Kojima, T | 1 |
| Suzuki, M | 1 |
| Osawa, Y | 1 |
| Ohnishi, K | 1 |
| Daibata, M | 1 |
| Murate, T | 1 |
1 other study available for pd 98059 and Aggressive Natural Killer Cell Leukemia
| Article | Year |
|---|---|
Involvement of KRAS G12A mutation in the IL-2-independent growth of a human T-LGL leukemia cell line, PLT-2.
Topics: Calcium-Calmodulin-Dependent Protein Kinases; Cell Line, Tumor; Cell Proliferation; Flavonoids; Huma | 2012 |